Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO)

CUSIP: 589492107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Ordinary Shares, par value GBP 0.003 per share
Shares outstanding
792,553,191
Total 13F shares
90,856,815
Share change
+3,196,563
Total reported value
$145,372,152
Put/Call ratio
276%
Price per share
$1.60
Number of holders
67
Value change
-$12,163,504
Number of buys
34
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 589492107?
CUSIP 589492107 identifies MREO - Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) as of Q4 2021

As of 31 Dec 2021, Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 90,856,815 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Rubric Capital Management LP, Point72 Asset Management, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, Vivo Capital, LLC, Rock Springs Capital Management LP, CITADEL ADVISORS LLC, HHLR ADVISORS, LTD., Holocene Advisors, LP, and COMMODORE CAPITAL LP. This page lists 67 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.